RevitalVision

RevitalVision is a commercial-stage digital vision therapy company focused on neuro-visual training to improve visual performance in amblyopia and other visual impairments. Its core product is a non-invasive, software-based perceptual learning program that uses personalized visual stimulation, including Gabor patch-based exercises, to enhance cortical visual processing. The company markets the program directly to patients and eye-care professionals for conditions including amblyopia, post-cataract and post-LASIK visual deficits, mild myopia, and selected low-vision conditions. RevitalVision describes its therapy as FDA-cleared for amblyopia in patients aged 9 and older and positions the product as an adjunct or alternative to conventional optical management. The business appears to operate under Talshir Medical Technologies, the global owner and marketer of the RevitalVision technology and intellectual property.